The initial A 2A AR*-NECA complex was obtained by combining structural information from the A 2A AR-ZM241385 structure (PDB code 4EIY 1 ) and the two active-state A 2A AR* structures in complex with the agonists UK432097 (PDB code 3QAK 2 ) and NECA (PDB code 2YDV 3 ), as reported earlier 4, 5 . Briefly, a morphing process was applied between the initial (A 2A AR-ZM241385) and target receptor structures (A 2A AR*-UK432097), followed by superposition of the A 2A AR*-NECA complex where the ligand and key water molecules were retained. 3 Note that the latter crystal structure was not suitable as a direct starting point for our calculations because it contains some stabilizing mutations of residues that we aimed to study, and a deformed helix VII backbone due to a cis-proline in the NPxxY motif. Standard residue sequence numbering for the human A 2A AR is used herein, with superscripts according to the GPCR-specific position numbering based on TM helix conservation 6 . The receptor complex was embedded in a POPC lipid bilayer, solvated and further equilibrated using GROMACS4.0.5 7 with the protocol implemented in the GPCR-ModSim web-server 8 . For subsequent simulations of the binding site region a 25 Å radius sphere was then extracted from the equilibrated system (including lipids and water molecules), centred on the C2 carbon of the adenine moiety of NECA.
MD simulations were needed (left side of the thermodynamic cycle in Fig 1) , according to the following equation:
(1) b NB = non-detectable radioligand binding. The value corresponding to the experimental detection threshold is indicated within parentheses.
